Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Richmond › NPI 1851454011
Lab

Permanente Medical Group, INC.

Permanente Medical Group, INC. was paid $51.11M by Medicaid between Jan 2018 and Dec 2024, across 266 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 10% of everything it billed.

33Billing provider infoPERMANENTE MEDICAL GROUP, INC.
RICHMOND, CA 94804
33aNPI1851454011assigned 12/19/2006
28Total paid$51.11M
24GClaims9,908,802
24DCodes billed266
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#18 of 561
Median peer was paid$222K
This provider vs. median230×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018917,535$147K
2019948,427$345K
2020784,204$2.62M
20211,258,183$4.34M
20221,392,167$5.41M
20231,796,487$7.87M
2024incomplete2,811,799$30.38M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
84443 Thyroid stimulating hormone (TSH) 10% 558,250 547,539 $5.32M
83036 Hemoglobin; glycosylated (A1C) 8.6% 727,847 721,077 $4.39M
36415 Collection of venous blood by venipuncture 8.4% 1,243,086 1,163,111 $4.29M
80061 Lipid panel 6.7% 447,094 443,776 $3.42M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4.8% 152,507 150,930 $2.45M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4.7% 59,041 55,221 $2.42M
82565 4.7% 765,935 736,092 $2.39M
82728 3.2% 286,608 281,899 $1.64M
84460 3.2% 616,361 595,644 $1.64M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.1% 376,140 357,608 $1.56M
83970 2.9% 37,090 36,043 $1.49M
85027 2.7% 433,449 426,048 $1.39M
254 more codes
84132 2.4% 367,394 $1.25M
82607 2.4% 114,536 $1.22M
84153 1.7% 61,711 $889K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.7% 12,827 $874K
80051 1.5% 154,142 $790K
83550 1.5% 147,807 $776K
84450 1.3% 246,604 $671K
84295 1.2% 168,562 $603K
83540 1.1% 148,427 $539K
82947 1.0% 284,167 $531K
84439 <1% 109,308 $476K
83735 <1% 90,591 $457K
84520 <1% 171,772 $451K
82310 <1% 109,638 $415K
85610 <1% 113,621 $408K
82247 <1% 135,694 $393K
84075 <1% 127,031 $369K
82040 <1% 87,203 $329K
86360 <1% 11,887 $311K
82105 <1% 22,820 $304K
84403 <1% 32,466 $303K
80197 <1% 19,745 $285K
84100 <1% 62,303 $262K
87799 <1% 6,911 $209K
84550 <1% 52,443 $195K
80048 Basic metabolic panel (calcium, ionized) <1% 29,445 $193K
82985 <1% 12,762 $182K
82746 <1% 16,392 $174K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 28,662 $172K
86480 <1% 29,342 $167K
83721 <1% 30,652 $159K
82248 <1% 43,369 $133K
84146 <1% 22,419 $130K
82670 <1% 16,056 $120K
81443 <1% 3,489 $119K
82378 <1% 8,132 $119K
83993 <1% 11,761 $117K
83690 <1% 38,111 $108K
83001 <1% 21,283 $105K
80069 <1% 15,372 $100K
83655 <1% 50,916 $98K
86359 <1% 4,403 $96K
86355 <1% 4,403 $96K
86357 <1% 4,391 $95K
82550 <1% 26,182 $95K
86304 <1% 6,722 $90K
82024 <1% 2,745 $88K
87497 <1% 5,236 $80K
84480 <1% 14,100 $80K
80164 <1% 7,901 $79K
85014 <1% 50,246 $76K
85018 <1% 50,046 $76K
82533 <1% 8,411 $75K
84702 <1% 15,343 $65K
83002 <1% 12,916 $63K
86850 <1% 23,837 $62K
81025 <1% 33,194 $61K
80349 <1% 8,381 $56K
83615 <1% 16,906 $54K
83718 <1% 13,754 $54K
86301 <1% 3,295 $52K
81329 <1% 5,700 $49K
82627 <1% 8,714 $49K
82977 <1% 14,407 $44K
86366 <1% 134 $41K
80361 <1% 11,194 $40K
82950 <1% 29,388 $40K
82465 <1% 19,439 $38K
84703 <1% 22,322 $38K
82150 <1% 14,469 $36K
80346 <1% 3,407 $36K
82397 <1% 4,117 $34K
86635 <1% 1,645 $33K
84402 <1% 3,458 $31K
82785 <1% 4,289 $31K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,316 $31K
82374 <1% 7,683 $31K
86300 <1% 2,451 $31K
85045 <1% 10,854 $31K
86901 <1% 29,811 $30K
86900 <1% 29,812 $30K
86376 <1% 6,848 $30K
82435 <1% 8,132 $28K
86147 <1% 2,187 $26K
80158 <1% 1,150 $25K
80325 <1% 3,714 $24K
84425 <1% 9,751 $24K
84154 <1% 1,205 $23K
82951 <1% 5,207 $23K
87338 <1% 11,928 $22K
83516 <1% 1,452 $22K
86146 <1% 1,873 $21K
80178 <1% 6,124 $20K
85397 <1% 2,975 $20K
84478 <1% 7,674 $20K
80230 <1% 712 $19K
81338 <1% 141 $19K
83090 <1% 2,004 $18K
84144 <1% 2,378 $18K
82570 <1% 11,083 $18K
87350 <1% 1,092 $17K
85246 <1% 3,085 $17K
80321 <1% 1,737 $16K
80175 <1% 2,819 $16K
80156 <1% 1,331 $15K
86707 <1% 923 $15K
80053 Comprehensive metabolic panel <1% 988 $14K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,740 $14K
84445 <1% 3,190 $14K
85240 <1% 3,114 $13K
80185 <1% 1,319 $13K
84630 <1% 7,718 $12K
81219 <1% 130 $12K
81279 <1% 184 $11K
86618 <1% 1,240 $10K
82525 <1% 6,441 $10K
86255 <1% 217 $10K
82656 <1% 1,463 $10K
80169 <1% 326 $10K
84681 <1% 766 $10K
86235 <1% 129 $9K
83519 <1% 442 $9K
84590 <1% 3,851 $8K
80356 <1% 1,379 $8K
84300 <1% 1,552 $7K
80162 <1% 265 $7K
86870 <1% 439 $7K
82787 <1% 927 $7K
85705 <1% 2,514 $7K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 228 $7K
81401 <1% 208 $6K
88377 <1% 29 $6K
84207 <1% 3,306 $6K
82610 <1% 467 $6K
80177 <1% 1,651 $6K
86341 <1% 564 $6K
83520 <1% 1,193 $6K
80195 <1% 319 $6K
84244 <1% 1,748 $6K
86381 <1% 2,276 $5K
87563 <1% 800 $5K
82952 <1% 4,681 $5K
85730 <1% 2,397 $5K
84182 <1% 124 $5K
86812 <1% 1,528 $5K
82232 <1% 204 $5K
82010 <1% 820 $5K
84432 <1% 859 $5K
86800 <1% 863 $5K
86141 <1% 450 $5K
84305 <1% 2,630 $5K
82330 <1% 350 $4K
83525 <1% 1,051 $4K
82166 <1% 453 $4K
88360 <1% 24 $4K
80365 <1% 1,240 $4K
86015 <1% 2,616 $4K
87496 <1% 168 $4K
85250 <1% 760 $4K
86665 <1% 1,058 $4K
84446 <1% 1,520 $3K
80354 <1% 357 $3K
85270 <1% 724 $3K
86039 <1% 939 $3K
82088 <1% 1,066 $3K
86611 <1% 584 $3K
86256 <1% 262 $3K
87305 <1% 108 $3K
80184 <1% 78 $2K
86041 <1% 206 $2K
80320 <1% 265 $2K
80323 <1% 787 $2K
82705 <1% 1,295 $2K
86790 <1% 323 $2K
86664 <1% 1,070 $2K
86316 <1% 157 $2K
86769 <1% 370 $2K
82668 <1% 511 $2K
82784 <1% 922 $2K
80348 <1% 2,238 $2K
87340 <1% 363 $2K
82747 <1% 470 $1K
82085 <1% 972 $1K
84155 <1% 694 $1K
82180 <1% 182 $1K
85549 <1% 272 $1K
84080 <1% 185 $1K
80299 <1% 41 $1K
86340 <1% 166 $1K
84540 <1% 439 $1K
86337 <1% 167 $1K
87535 <1% 182 $1K
83835 <1% 63 $1K
82365 <1% 431 $1K
86317 <1% 79 $1K
80353 <1% 108 $1K
80358 <1% 420 $1K
87449 <1% 29 $966.72
86645 <1% 749 $926.61
85008 <1% 8,519 $864.94
82157 <1% 310 $767.84
80183 <1% 180 $732.32
85300 <1% 86 $727.49
85303 <1% 75 $726.60
82523 <1% 50 $725.00
86644 <1% 551 $717.61
82107 <1% 16 $713.65
83951 <1% 16 $707.00
87902 <1% 12 $693.60
86747 <1% 99 $687.57
83825 <1% 341 $637.15
82175 <1% 309 $608.06
82595 <1% 252 $595.00
83945 <1% 431 $594.74
83986 <1% 466 $569.98
84560 <1% 433 $569.68
84105 <1% 428 $568.68
84392 <1% 428 $568.15
84133 <1% 429 $563.65
82507 <1% 431 $553.15
86692 <1% 217 $542.85
82340 <1% 429 $529.15
80145 <1% 13 $495.00
80373 <1% 235 $484.06
85306 <1% 41 $468.63
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 27 $436.48
85007 <1% 2,002 $387.78
85004 <1% 38 $370.00
86606 <1% 54 $366.80
82172 <1% 97 $343.15
82652 <1% 78 $310.00
86036 <1% 70 $297.41
84376 <1% 333 $292.38
84255 <1% 100 $277.20
86880 <1% 56 $249.35
86160 <1% 15 $248.45
86200 <1% 142 $227.50
86706 <1% 163 $174.72
86886 <1% 63 $93.80
86774 <1% 24 $93.15
3044F <1% 171,180 $50.00
86777 <1% 12 $47.04
86778 <1% 12 $47.04
86704 <1% 17 $30.24
99429 0% 720 $0.00
3052F 0% 10,396 $0.00
3074F 0% 1,048 $0.00
80324 0% 590 $0.00
85305 0% 40 $0.00
99000 0% 13 $0.00
3046F 0% 15,419 $0.00
3051F 0% 18,219 $0.00
84165 0% 146 $0.00
3078F 0% 1,010 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWEST, PATRICIA (CHIEF FINANCIAL OFFICER)
Parent organizationPERMANENTE MEDICAL GROUP, INC.
Same official

Other billing entities under WEST, PATRICIA

Full network →
ProviderLocationPaid
Permanente Medical Group INCStockton, CA$125.88M
Permanente Medical Group INCRichmond, CA$37.82M
Permanente Medical Group, INC.Berkeley, CA$31.35M
Permanente Medical Group INCVallejo, CA$16.13M
Permanente Medical Group INCSanta Clara, CA$8.46M
Permanente Medical Group INCSan Francisco, CA$5.40M
Permanente Medical Group INCRedwood City, CA$4.45M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.